Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q4 FY22 results · Jan–Mar 2022

Krsnaa Diagnostics reported revenue from operations of ₹108.25 crore and net profit of ₹17.94 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations108.25——106.47+1.7%
Other income4.10——4.34−5.4%
Total income112.35——110.81+1.4%
Profit before tax19.89——21.35−6.9%
Net profit for the period17.94——16.33+9.8%
EPS, basic (₹)5.40——5.67−4.8%
Net margin (%)16.6—15.3
Standalone · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations107.84——106.31+1.4%
Other income4.12——4.34−5.0%
Total income111.97——110.65+1.2%
Profit before tax22.06——22.25−0.9%
Net profit for the period19.33——17.23+12.2%
EPS, basic (₹)5.85——5.97−2.0%
Net margin (%)17.9—16.2
Consolidated
Filed with BSE
10 Jun 2022, 13:07 IST
Board meeting
28 May 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
10 Jun 2022, 13:07 IST
Board meeting
28 May 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE